EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Bristol Myers Squibb Company $BMY Shares Sold by Valeo Financial Advisors LLC
Osaic Holdings Inc. Increases Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb launches AI-led content hub 'Mosaic' with Accenture as part of $130 mn investment
Is Bristol Myers (BMY) Undervalued After Its Recent Share Price Rebound?
Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies
Harbour BioMed, Bristol Myers More Than $1.1 Bln Deal For Next-Gen Multi-Specific Antibodies
Building a Healthier Future Together: Strengthening Cancer Care Across Africa Through Partnership
Top Pharmaceutical Stocks To Consider - December 16th
Shorepoint Capital Partners LLC Takes Position in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb named industry company of the year at Pharma Industry Awards 2025
Assessing Bristol Myers Squibb After 16% Rally and New Drug Approvals in 2025
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry
Best Dividend Stocks To Follow Today - December 15th - Markets Daily
Bristol Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Bank of America
Bristol Myers Squibb (NYSE:BMY) Stock Unloaded Rep. Julie Johnson
Pitcairn Co. Trims Position in Bristol Myers Squibb Company $BMY - Markets Daily
National Bank of Canada FI Acquires 860,464 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by Cullen Capital Management LLC
National Bank of Canada FI Has $95.80 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Pitcairn Co. Trims Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Marex Group plc Takes Position in Bristol Myers Squibb Company $BMY - Daily Political
From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer
Bristol Myers Squibb Company $BMY Shares Purchased by AQR Capital Management LLC
Bristol Myers Squibb Company $BMY is Birchview Capital LP's Largest Position - Stock Observer
Bristol Myers Squibb Company $BMY Shares Bought by Bellevue Group AG - Stock Observer
Bristol Myers Squibb (NYSE:BMY) Price Target Raised to $55.00 - Stock Observer
Bcwm LLC Boosts Stake in Bristol Myers Squibb Company $BMY - Daily Political
Dividend Stocks To Follow Now - December 12th - Markets Daily
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Lowers Holdings in Bristol Myers Squibb Company $BMY
Peapack Gladstone Financial Corp Reduces Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer
Australia & NZ CTCL Market to Reach USD 359.10M by 2035
Bristol Myers Squibb Company (NYSE:BMY) Raises Dividend to $0.63 Per Share - Markets Daily
Bristol Myers Squibb Company (NYSE:BMY) Plans Dividend Increase - $0.63 Per Share
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
Bristol-Myers Squibb (BMY) Receives a Hold from Wells Fargo | Markets Insider
Wells Fargo & Company Forecasts Strong Price Appreciation for Bristol Myers Squibb (NYSE:BMY) Stock - Markets Daily
Jefferies Remains Bullish on Bristol-Myers Squibb Company (BMY)
Did New Gotistobart Data Just Shift BioNTech's (BNTX) Oncology-Led Diversification Narrative? - Simply Wall St News
Daiwa Securities Group Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY
Bank of Nova Scotia Buys 183,478 Shares of Bristol Myers Squibb Company $BMY
China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer | South China Morning Post
Taking Stock of Bristol-Myers Squibb (BMY): Exploring Valuation After Recent Share Price Momentum
Somatic evolution following cancer treatment in normal tissue
Non-Hodgkin Lymphoma Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb
Myelofibrosis Market to Expand Significantly by 2034, States DelveInsight Report | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros Therapeutics
Bristol Myers Squibb Company $BMY Shares Bought by Investment Management Corp of Ontario
State Street Corp Reduces Holdings in Bristol Myers Squibb Company $BMY
66,361 Shares in Bristol Myers Squibb Company $BMY Bought by SVB Wealth LLC
Natixis Sells 51,702 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb (BMY) Is Up 5.1% After Expanded Breyanzi MZL Approval Has The Bull Case Changed?
Leerink Maintains Outperform Rating as Bristol Myers (BMY) Expands ADEPT-2 Enrollment
14,601 Shares in Bristol Myers Squibb Company $BMY Purchased by ESG Planning DBA Harper Investing - Daily Political
Mirabella Financial Services LLP Trims Stock Position in Bristol Myers Squibb Company $BMY
Bristol-Myers Squibb (BMY) Gets a Buy from Jefferies | Markets Insider
Amundi Purchases 513,255 Shares of Bristol Myers Squibb Company $BMY
91,645 Shares in Bristol Myers Squibb Company $BMY Acquired by 1832 Asset Management L.P.
Jim Cramer on Bristol-Myers' Recent Stock Gain: "Unbelievable"
Bristol Myers Squibb Company $BMY Shares Sold by Mirabella Financial Services LLP - Daily Political
Dodge & Cox Trims Position in Bristol Myers Squibb Company $BMY - Markets Daily
First Trust Advisors LP Has $212.59 Million Holdings in Bristol Myers Squibb Company $BMY
US Acute Myeloid Leukemia Market Size & Share Forecast 2025-2033 | Taiwan News | Dec. 5, 2025 10:13
Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma
Tigerlily Foundation Launches the "Bliss Collective: Brunch & Sip" Series to Empower, Educate, and Uplift Women Nationwide | Morningstar
Jim Cramer Commented on 10 Stocks and the Recent Macro Rally
Phreesia News | Markets Insider
CW Advisors LLC Boosts Position in Bristol Myers Squibb Company $BMY - Markets Daily
CW Advisors LLC Increases Stock Holdings in Bristol Myers Squibb Company $BMY
A delayed clinical trial actually boosted Bristol Myers Squibb's stock. Here's why. | Morningstar
insitro Appoints R&D Veteran Stephen Hitchcock and AI Visionary Vijay Pande as Scientific Advisors
Independent Franchise Partners LLP Increases Holdings in Bristol Myers Squibb Company $BMY
The Bull Case For BioNTech (BNTX) Could Change Following Higher Guidance And Oncology Progress - Learn Why
Bristol-Myers Squibb (BMY): Assessing Value After a Recent Short-Term Share Price Rebound
River Road Asset Management LLC Decreases Position in Bristol Myers Squibb Company $BMY - Markets Daily
Me Too Drugs Industry Research Report 2025: Market to Reach $541.86 Million by 2030, Driven by Lower R&D Risk, Therapeutic Alternatives, and Opportunities from Patent Expirations
Smith Moore & CO. Decreases Stake in Bristol Myers Squibb Company $BMY - Markets Daily
River Road Asset Management LLC Sells 67,650 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Research Analysts' Recent Ratings Updates for Bristol Myers Squibb (BMY) - Markets Daily
Edgestream Partners L.P. Acquires 85,066 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Acquired by Arrowstreet Capital Limited Partnership
Smith Moore & CO. Sells 1,262 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study
Biologics Manufacturing Market: Segment Forecasts Across Global Regions - Express Press Release Distribution
Wealthedge Investment Advisors LLC Buys New Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Purchased by Railway Pension Investments Ltd
Round Hill Asset Management Buys 30,016 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Shelton Capital Management Cuts Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political
Claret Asset Management Corp Increases Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration
BMY Gains Attention as Bayer Reports FXIa Trial Success
Trustmark Bank Trust Department Sells 32,341 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
BristolMyers News
Gold price prediction: what will drive XAU/USD price higher in 2026?
What is the price of gold today: How to start investing in gold as a beginner?
What’s driving BTC/USD: Will Bitcoin (BTC) price hit a new ATH in 2026?
